Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $85.25 USD
Change Today +1.99 / 2.39%
Volume 7.9K
MLAB On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

mesa laboratories inc (MLAB) Snapshot

Open
$83.00
Previous Close
$83.26
Day High
$85.50
Day Low
$83.00
52 Week High
06/20/14 - $89.90
52 Week Low
09/23/14 - $54.60
Market Cap
301.4M
Average Volume 10 Days
11.3K
EPS TTM
$2.78
Shares Outstanding
3.5M
EX-Date
05/27/15
P/E TM
30.7x
Dividend
$0.64
Dividend Yield
0.73%
Current Stock Chart for MESA LABORATORIES INC (MLAB)

Related News

No related news articles were found.

mesa laboratories inc (MLAB) Related Businessweek News

No Related Businessweek News Found

mesa laboratories inc (MLAB) Details

Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products. It operates through three segments: Instruments, Biological Indicators, and Continuous Monitoring. The Instruments segment offers data loggers, medical meters and calibration solutions, gas flow calibration and air sampling equipment, and torque testing systems for use in healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and semiconductor industries. The Biological Indicators segment manufactures and markets biological indicators, such as spore strips, self-contained products, and culture media, as well as distributes chemical indicators used to assess the effectiveness of sterilization processes, including steam, gas, hydrogen peroxide, and radiation in the hospital, dental, medical device, and pharmaceutical industries. The Continuous Monitoring segment designs, develops, and markets systems that are used to monitor various environmental parameters, such as temperature, humidity, and differential pressure used for hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and a range of other laboratory and industrial environments. The company sells its products through direct sales, marketing staff, and distributors in the United States, Europe, Africa, Australia, Asia, South America, Canada, and Central America. Mesa Laboratories, Inc. was founded in 1982 and is headquartered in Lakewood, Colorado.

273 Employees
Last Reported Date: 06/4/14
Founded in 1982

mesa laboratories inc (MLAB) Top Compensated Officers

Chief Executive Officer, President, Treasurer...
Total Annual Compensation: $302.5K
Chief Financial Officer, Chief Accounting Off...
Total Annual Compensation: $205.0K
Chief Sales & Marketing Officer and Executive...
Total Annual Compensation: $195.0K
Senior Vice President of Operations
Total Annual Compensation: $150.0K
Senior Vice President of Operations
Total Annual Compensation: $145.0K
Compensation as of Fiscal Year 2014.

mesa laboratories inc (MLAB) Key Developments

Mesa Laboratories Inc. Announces Board Changes

Effective April 8, 2015, Luke R. Schmieder retired as a director and the Chairman of the board of directors of Mesa Laboratories Inc. Mr. Schmieder served as a director and Chairman of the board of directors of the company since March 1982 and as the company's Chief Executive Officer and Treasurer from its inception in March 1982 through March 2009. The board of directors, upon the recommendation of the Nominating and Governance Committee, appointed John Schmieder to fill the remaining term of the director vacancy created by Luke R. Schmieder's retirement. In addition, the board of directors, upon the recommendation of the Nominating and Governance Committee, appointed H. Stuart Campbell, a current member of the board of directors since 1983, as the new Chairman of the Board of Directors. Both the appointment of John Schmieder as a director and the appointment of H. Stuart Campbell as the Chairman of the board of directors were effective April 8, 2015.

Mesa Laboratories Declares Quarterly Dividend Payable on June 15, 2015

Mesa Laboratories Inc. announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 15, 2015, to shareholders of record at the close of business on May 29, 2015.

Mesa Laboratories Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014

Mesa Laboratories Inc. announced unaudited consolidated earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the company reported revenues of $17,830,000 compared to $13,116,000 a year ago. Operating income was $3,708,000 compared to $2,806,000 a year ago. Earnings before income taxes were $3,713,000 compared to $2,727,000 a year ago. Net income was $2,403,000 or $0.66 per diluted share compared to $1,746,000 or $0.48 per diluted share a year ago. On a non-GAAP basis, adjusted net income (which excludes the non- cash impact of amortization of intangible assets, net of tax) for the third quarter increased 40% to $3,175,000 or $0.87 per diluted share of common stock as compared to $2,273,000 or $0.62 per diluted share of common stock for the same quarter last year. Net income for the third quarter was impacted by an unusual item consisting of $460,000 (before tax) of expenses associated with uncollected sales tax liabilities. For the nine months, the company reported revenues of $52,770,000 compared to $37,010,000 a year ago. Operating income was $11,663,000 compared to $8,364,000 a year ago. Earnings before income taxes were $11,349,000 compared to $8,680,000 a year ago. Net income was $7,344,000 or $2.01 per diluted share compared to $5,538,000 or $1.54 per diluted share a year ago. Net income for the nine months ended December 31, 2014 was impacted by the same third quarter unusual item. Adjusted net income for the nine months ended December 31, 2014 increased 40% to $9,570,000 or $2.62 per diluted share of common stock as compared to $6,847,000 or $1.91 per diluted share of common stock for the same period last year. Adjusted net income for the third quarter and the nine months ended December 31, 2014 was impacted by the same unusual items.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MLAB:US $85.25 USD +1.99

MLAB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cantel Medical Corp $48.03 USD -0.10
Danaher Corp $83.30 USD -1.39
STERIS Corp $70.76 USD +0.06
Thermo Fisher Scientific Inc $130.02 USD +0.47
Transcat Inc $10.10 USD -0.0299
View Industry Companies
 

Industry Analysis

MLAB

Industry Average

Valuation MLAB Industry Range
Price/Earnings 28.2x
Price/Sales 4.3x
Price/Book 4.1x
Price/Cash Flow 27.2x
TEV/Sales 3.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MESA LABORATORIES INC, please visit www.mesalabs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.